transplant rejection

Her cause of death is believed to have been transplant rejection.

Drugs that prevent transplant rejection must be taken for the rest of the patient's life.

Blacks and Asians were also more likely to experience transplant rejection.

The failure of the body to accept an organ is known as transplant rejection.

For a list of immunosuppressive drugs, see the transplant rejection page.

It also plays a major role in transplant rejection.

He had stopped taking his transplant rejection drugs and was found near the side of a Florida highway by a stranger.

But studies are under way on new methods of preventing transplant rejection that promise to have few if any serious side effects.

Transplant rejection is a primary concern, both immediately after the surgery and continuing throughout the patient's life.

Transplant rejection is a serious condition and must be treated as soon as possible.

This is particularly important in the case of transplanted tissue, because it could lead to transplant rejection.

Transplant rejection between two such individuals virtually never occurs.

Some of the same ones that I deal with in transplant rejection, in fact."

Doctors must match donors to recipients to reduce the risk of transplant rejection.

Using other drugs that treat organ transplant rejection along with this drug may increase these tendencies.

The first to be approved was muromonab-CD3 in 1986, to treat transplant rejection.

They are the major cause of organ transplant rejections.

Mycophenolate is used for the prevention of organ transplant rejection.

It is extensively used to control transplant rejection reactions.

There is a greater risk of infection because of the drugs that must be taken to prevent transplant rejection.

Transplant patients already take many medications to prevent transplant rejection.

A transplant rejection is the body's destruction of a newly introduced organ or tissue.

This decreases the risk of transplant rejection and the need for another transplant.

The most important factor in transplant rejection is the part of the body's immune defenses called the complement protein system.

Together the companies have market dominance of cancer drugs, organ transplant rejection treatments and diagnostic testing.